Patents by Inventor Tomoki IKUTA

Tomoki IKUTA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Mucosal immunomodulator
    Patent number: 11089805
    Abstract: The present invention provides a mucosal immunomodulator comprising, as an active ingredient, at least one selected from the group consisting of compounds represented by the following formula (1), compounds represented by the following formula (2) and compounds represented by the following formula (3), and salts thereof.
    Type: Grant
    Filed: October 12, 2017
    Date of Patent: August 17, 2021
    Assignees: Yamada Bee Company, Inc., National University Corporation Kumamoto University
    Inventors: Shogo Misumi, Tomoki Ikuta, Tomoki Tatefuji, Hiroko Tani, Hiroshi Inooka
  • Genome stability enhancer
    Patent number: 10894067
    Abstract: Disclosed is a genome stability enhancer comprising, as an active ingredient, at least one member selected from the group consisting of enzyme-treated royal jelly, gnetum or its extract, and gnetin C.
    Type: Grant
    Filed: March 6, 2018
    Date of Patent: January 19, 2021
    Assignees: Yamada Bee Company, Inc., National Cancer Center, Tohoku University
    Inventors: Tomoki Ikuta, Shinobu Fukushima, Tomoki Tatefuji, Kenichi Yoshioka, Hitoshi Shirakawa
  • MUCOSAL IMMUNOSTIMULATOR
    Publication number: 20200093776
    Abstract: The present invention provides a mucosal immunostimulator comprising, as an active ingredient, at least one selected from the group consisting of saturated fatty acids represented by the following formula (1) and salts thereof: R—COOH??(1) wherein, in the formula (1), R represents an alkyl group having 7 to 11 carbon atoms substituted with one hydroxy group.
    Type: Application
    Filed: September 27, 2019
    Publication date: March 26, 2020
    Inventors: Shogo MISUMI, Tomoki IKUTA, Tomoki TATEFUJI
  • GENOME STABILITY ENHANCER
    Publication number: 20200023017
    Abstract: Disclosed is a genome stability enhancer comprising, as an active ingredient, at least one member selected from the group consisting of enzymatically degraded royal jelly, gnetum or its extract, and gnetin C.
    Type: Application
    Filed: March 6, 2018
    Publication date: January 23, 2020
    Inventors: Tomoki Ikuta, Shinobu Fukushima, Tomoki Tatefuji, Kenichi Yoshioka, Hitoshi Shirakawa
  • MUCOSAL IMMUNOMODULATOR
    Publication number: 20190230967
    Abstract: The present invention provides a mucosal immunomodulator comprising, as an active ingredient, at least one selected from the group consisting of compounds represented by the following formula (1), compounds represented by the following formula (2) and compounds represented by the following formula (3), and salts thereof.
    Type: Application
    Filed: October 12, 2017
    Publication date: August 1, 2019
    Applicant: National Unversity Corporation Kumamoto University
    Inventors: Shogo MISUMI, Tomoki IKUTA, Tomoki TATEFUJI, Hiroko TANI, Hiroshi INOOKA
  • MUCOSAL IMMUNOSTIMULATOR
    Publication number: 20180104205
    Abstract: The present invention provides a mucosal immunostimulator comprising, as an active ingredient, at least one selected from the group consisting of saturated fatty acids represented by the following formula (1) and salts thereof: R—COOH??(1) wherein, in the formula (1), R represents an alkyl group having 7 to 11 carbon atoms substituted with one hydroxy group.
    Type: Application
    Filed: April 4, 2016
    Publication date: April 19, 2018
    Inventors: Shogo MISUMI, Tomoki IKUTA, Tomoki TATEFUJI